Breaking news, the University of Texas, Austin
is bridging the gap between research and commercialization with its new $1 million dollar drug development lab called UT Advance
. The lab is aimed at helping the researcher move their projects farther down the drug pipeline. The University has an, “outstanding preclinical research programs in drug development and targeted drug delivery,"
said M. Lynn Crismon
, dean of the College of Pharmacy. "This facility will help our researchers … more efficiently and effectively to get their discoveries into human trials."
William O. Williams has the honor of being the first researcher to have a new drug tested at the UT Advance lab. His aerosolized drug is used for lung transplant patients to keep the immune system from rejecting the transplant. Dr. William’s lab explores a variety of delivery methods such as: depot drug delivery, oral drug delivery, pulmonary/nasal drug delivery, and aerosol device technology to optimize drug delivery depending upon its intended target.